3,4-methylenedioxyamphetamine has been researched along with Diabetes Mellitus, Type 1 in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fallon, A | 1 |
| Dunne, F | 1 |
| Neithercott, T | 1 |
1 review available for 3,4-methylenedioxyamphetamine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Breastfeeding practices that support women with diabetes to breastfeed.
Topics: Breast Feeding; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; | 2015 |
1 other study available for 3,4-methylenedioxyamphetamine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Dating game. How to involve your significant other in your significant disease.
Topics: Communication; Diabetes Mellitus, Type 1; Female; Humans; Interpersonal Relations; Love; Male; Socia | 2012 |